What did @davidsamadimd actually say?
Dr. David Samadi, a urologic oncologist with a large social media following, listed several symptoms he says men with low testosterone should watch for: fatigue, low energy, belly fat gain, muscle loss, reduced libido, weight gain, and hair loss. He then made a specific clinical claim: "check your testosterone early in the morning before 9 a.m." because testosterone peaks around 5 a.m. He also connected morning erections to that testosterone peak. The video closes with a vague promise that "there are many treatment options" and men will "wake up like this" after addressing low T. The symptom list is broadly reasonable. The timing advice is clinically legitimate. But the framing throughout the video leans heavily on anecdote and sidesteps the complexity of actually diagnosing hypogonadism.
Does the science back this up?
The core symptom claims are supported, though not perfectly. Yes, hypogonadism is associated with fatigue, reduced libido, increased fat mass, and decreased muscle. The morning testing window is genuinely recommended in clinical guidelines. Where things get shaky is the implied simplicity: get checked, levels are low, get treated, problem solved.
The symptoms Samadi lists are real but are also associated with depression, sleep apnea, hypothyroidism, metabolic syndrome, and aging itself. Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that the relationship between testosterone levels and symptoms is weak at the population level. The Endocrine Society guidelines recommend at least two morning measurements on separate days before diagnosing hypogonadism, a detail missing from this video entirely. Travison et al. (2017, JCEM) also found that morning erections correlate with testosterone levels, so that specific claim holds up reasonably well. But correlation is not a clean diagnostic tool.
What did they get wrong (or right)?
Credit where it is due: the before-9 a.m. testing window is accurate and clinically standard. The American Urological Association and Endocrine Society both recommend morning serum total testosterone testing, ideally between 7 and 10 a.m., because diurnal variation is well-documented. The 5 a.m. peak claim is directionally correct. Brambilla et al. (2009, International Journal of Andrology) confirmed circadian testosterone patterns with peak levels in early morning hours.
What Samadi gets wrong is the diagnostic simplicity. He treats these symptoms as a checklist that points straightforwardly to low testosterone, without mentioning that a diagnosis requires confirmed low serum levels on repeat testing combined with clinical symptoms. "Losing hair" is listed casually, but hair loss in men is primarily driven by DHT sensitivity and genetics, not testosterone levels. And the phrase "they'll wake up like this" gestures at treatment without disclosing what TRT actually involves, its risks, its limitations, or the fact that exogenous testosterone suppresses natural production and can impair fertility.
What should you actually know?
If you relate to these symptoms, getting a morning testosterone test is a reasonable first step. That part Samadi got right. But a single number on a lab report does not make a diagnosis. The Endocrine Society and American Urological Association both require two separate low readings combined with consistent symptoms before initiating treatment. Total testosterone below 300 ng/dL is generally used as a threshold, but free testosterone and SHBG levels matter too.
More importantly, the symptoms in this video are not specific to low T. A man who is tired, gaining weight, losing libido, and losing muscle mass should also be evaluated for sleep disorders, thyroid dysfunction, depression, and metabolic issues. Jumping straight to TRT without ruling those out is poor medicine. TRT itself carries real considerations: erythrocytosis, suppression of sperm production, and cardiovascular effects that are still being studied. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found no increased cardiovascular risk in men with hypogonadism treated with testosterone, which is reassuring, but that does not mean TRT is consequence-free or appropriate for everyone with vague symptoms.